Ligand profile
CHEMBL1452612
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_01981 — Chaperone protein dnaK
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1452612- UniProt (similar protein)
Q66ET0- Target protein
- KP13_01981
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 85.4
- −1 ≤ LogP ≤ 5 2.43
- MW ≤ 500 Da 260.2
- LogP ≤ 5 2.43
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 85.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccc(CNC(=O)c2ccc([N+](=O)[O-])o2)cc1Cc1ccc(CNC(=O)c2ccc([N+](=O)[O-])o2)cc1
InChI=1S/C13H12N2O4/c1-9-2-4-10(5-3-9)8-14-13(16)11-6-7-12(19-11)15(17)18/h2-7H,8H2,1H3,(H,14,16)InChI=1S/C13H12N2O4/c1-9-2-4-10(5-3-9)8-14-13(16)11-6-7-12(19-11)15(17)18/h2-7H,8H2,1H3,(H,14,16)
SQYYJVWHHJKTSQ-UHFFFAOYSA-NSQYYJVWHHJKTSQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Activity
- Active
- Binding sites
- PF00012
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1452612 →
- UniProt UniProt Q66ET0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1452612”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01981.
PDB 20
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).